Hikma Pharmaceuticals PLC 2022 Sustainability Report
Company: Hikma Pharmaceuticals PLC
Sector: Manufacturing
Country: United Kingdom
Year: 2022
Type: Sustainability Report
Pages: 50
The report highlights Hikma's 2022 progress in reducing market-based Scope 1 and 2 emissions, reporting a 9% year-on-year decrease and a 25% reduction including RECs against the 2020 base year. It also expands Scope 3 reporting to include Business Travel and Employee Commuting, with 858,293 tCO2e reported for 2022 and external verification described. Workforce disclosures cover 8,536 full-time employees, diversity metrics, training and employee health and safety, including zero fatalities.
Reporting standards, commitments and assurance details are available with a free account.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.